NASDAQ : CNSY
Cerenome, Inc. — Financial statements
Healthcare · Medical - Pharmaceuticals · United States
Last price 1.74 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 13.21M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Cerenome, Inc. (CNSY) reported revenue of 4.20M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 4.20M | 5.21M | 5.82M | 4.91M | 224.00K | |
| Cost of Revenue | 12.51M | 8.38M | 10.58M | 9.69M | 9.70M | 5.32M |
| Gross Profit | -8.30M | -3.17M | -4.76M | -4.78M | -9.47M | -5.32M |
| Selling, General & Admin | 18.10M | 12.13M | 9.94M | 8.54M | 10.24M | 6.85M |
| Operating Expenses | 18.10M | 12.13M | 9.94M | 8.54M | 10.24M | 6.85M |
| Operating Income | -26.40M | -15.30M | -14.70M | -13.32M | -19.71M | -12.18M |
| Interest Expense | -22.00K | -548.00K | -179.00K | -395.00K | -711.00K | -932.00K |
| Interest & Investment Income | 334.00K | 116.00K | 273.00K | 400.00K | 147.00K | 19.00K |
| Other Non Operating Income (Expenses) | -6.66M | 1.62M | 1.00K | 6.00K | ||
| EBT Excluding Unusual Items | -26.09M | -22.39M | -12.98M | -13.32M | -20.27M | -13.08M |
| Gain (Loss) on Sale of Assets | -66.00K | |||||
| Pretax Income | -26.09M | -22.39M | -12.98M | -13.32M | -20.27M | -13.40M |
| Earnings From Continuing Operations | -26.09M | -22.39M | -12.98M | -13.32M | -20.27M | -13.40M |
| Net Income | -26.09M | -22.39M | -12.98M | -13.32M | -20.27M | -13.40M |
| Net Income to Common | -26.09M | -22.39M | -12.98M | -13.32M | -20.27M | -13.40M |
| Shares Outstanding (Basic) | 6.01M | 3.11M | 265.61K | 125.64K | 70.01K | 32.24K |
| Shares Outstanding (Diluted) | 6.01M | 3.11M | 308.03K | 125.64K | 70.01K | 32.24K |
| EPS (Basic) | -4.34 | -7.19 | -48.86 | -105.99 | -289.58 | -415.63 |
| EPS (Diluted) | -4.37 | -7.25 | -58.52 | -106.00 | -289.58 | -416.25 |
| Free Cash Flow | -23.55M | -20.84M | -10.70M | -13.01M | -13.48M | -10.42M |
| Free Cash Flow Per Share | -3.92 | -6.70 | -34.74 | -103.56 | -192.55 | -323.35 |
| Gross Margin | -197.57% | -60.73% | -81.66% | -97.23% | ||
| Operating Margin | -628.12% | -293.46% | -252.32% | -271.14% | -8,800.00% | |
| Profit Margin | -620.70% | -429.43% | -222.84% | -271.04% | -9,051.34% | |
| Free Cash Flow Margin | -560.29% | -399.81% | -183.72% | -264.83% | -6,018.30% | |
| EBITDA | -25.95M | -14.85M | -13.82M | -12.69M | -19.09M | -11.78M |
| EBITDA Margin | -284.92% | -237.34% | -258.35% | |||
| D&A For EBITDA | 455.00K | 445.00K | 872.00K | 628.00K | 619.00K | 395.00K |
| EBIT | -26.40M | -15.30M | -14.70M | -13.32M | -19.71M | -12.18M |
| EBIT Margin | -293.46% | -252.32% | -271.14% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.37M | 4.26M | 76.00K | 8.55M | 18.12M | 18.40M |
| Short-Term Investments | 6.22M | 4.36M | 3.53M | |||
| Cash & Short-Term Investments | 8.59M | 8.61M | 3.61M | 8.55M | 18.12M | 18.40M |
| Accounts Receivable | 1.76M | 322.00K | 571.00K | |||
| Other Receivables | 208.00K | |||||
| Receivables | 1.97M | 322.00K | 571.00K | |||
| Prepaid Expenses | 971.00K | 1.34M | 646.00K | 1.05M | 3.70M | 1.32M |
| Restricted Cash | 4.50M | |||||
| Other Current Assets | 244.00K | 394.00K | 436.00K | 234.00K | 7.00K | |
| Total Current Assets | 11.77M | 15.17M | 5.26M | 9.83M | 21.82M | 19.72M |
| Property, Plant & Equipment | 1.45M | 327.00K | 521.00K | 1.11M | 1.57M | 1.82M |
| Goodwill | 372.00K | 372.00K | 372.00K | 372.00K | 372.00K | 372.00K |
| Other Intangible Assets | 265.00K | 333.00K | 469.00K | 42.00K | 94.00K | 51.00K |
| Other Long-Term Assets | 170.00K | 123.00K | 12.00K | 32.00K | 12.00K | 16.00K |
| Total Assets | 14.03M | 16.32M | 6.63M | 11.39M | 23.87M | 21.98M |
| Accounts Payable | 7.55M | 3.28M | 9.47M | 4.76M | 8.36M | 2.61M |
| Accrued Expenses | 2.64M | 1.81M | 1.87M | 1.77M | 1.42M | |
| Short-Term Debt | 750.00K | 3.29M | ||||
| Current Portion of Long-Term Debt | 3.98M | 1.61M | 1.61M | |||
| Current Portion of Leases | 44.00K | 56.00K | 44.00K | 120.00K | 110.00K | 111.00K |
| Current Unearned Revenue | 927.00K | 927.00K | 927.00K | |||
| Other Current Liabilities | 46.00K | 4.66M | 122.00K | |||
| Total Current Liabilities | 8.57M | 12.31M | 15.55M | 10.73M | 11.85M | 5.87M |
| Long-Term Debt | 3.79M | 5.00M | ||||
| Long-Term Leases | 15.00K | 31.00K | 85.00K | 141.00K | 269.00K | |
| Long-Term Unearned Revenue | 1.92M | 1.64M | ||||
| Other Long-Term Liabilities | 1.00K | |||||
| Total Liabilities | 8.57M | 12.33M | 15.58M | 12.74M | 17.42M | 11.14M |
| Common Stock | 7.00K | 139.00K | 6.00K | 5.00K | 2.00K | 16.00K |
| Additional Paid-In Capital | 537.77M | 520.22M | 485.02M | 479.27M | 473.63M | 457.73M |
| Retained Earnings | -531.82M | -515.87M | -493.48M | -480.50M | -467.19M | -446.91M |
| Treasury Stock | -500.00K | -500.00K | -500.00K | -126.00K | ||
| Shareholders' Equity | 5.46M | 4.00M | -8.95M | -1.35M | 6.45M | 10.84M |
| Total Liabilities & Equity | 14.03M | 16.32M | 6.63M | 11.39M | 23.87M | 21.98M |
| Total Debt | 44.00K | 821.00K | 3.37M | 4.18M | 5.64M | 6.99M |
| Net Cash (Debt) | 8.54M | 7.79M | 239.00K | 4.37M | 12.47M | 11.41M |
| Net Cash Per Share | 1.42 | 2.50 | 0.78 | 34.81 | 178.18 | 353.84 |
| Filing Date Shares Outstanding | 7.59M | 6.86M | 679.99K | 171.04K | 93.63K | 59.13K |
| Total Common Shares Outstanding | 7.31M | 5.55M | 235.85K | 177.76K | 89.60K | 41.36K |
| Working Capital | 3.20M | 2.86M | -10.29M | -893.00K | 9.96M | 13.85M |
| Book Value Per Share | 0.75 | 0.72 | -37.94 | -7.58 | 71.93 | 261.99 |
| Tangible Book Value | 4.83M | 3.29M | -9.79M | -1.76M | 5.98M | 10.41M |
| Tangible Book Value Per Share | 0.66 | 0.59 | -41.51 | -9.91 | 66.73 | 251.76 |
| Machinery | 1.78M | 1.78M | 1.63M | 1.47M | 1.23M | |
| Leasehold Improvements | 1.81M | 1.81M | 1.81M | 1.81M | 1.66M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -26.09M | -22.39M | -12.98M | -13.32M | -20.27M | -13.40M |
| Depreciation & Amortization | 438.00K | 445.00K | 872.00K | 628.00K | 712.00K | 419.00K |
| Other Amortization | 190.00K | 389.00K | 546.00K | |||
| Loss (Gain) From Sale of Assets | -16.00K | 2.00K | 66.00K | |||
| Asset Writedown & Restructuring Costs | 117.00K | 250.00K | ||||
| Loss (Gain) From Sale of Investments | -2.00K | -9.00K | -111.00K | |||
| Stock-Based Compensation | 3.09M | 1.54M | 550.00K | 569.00K | 606.00K | 606.00K |
| Other Operating Activities | 22.00K | 5.69M | -2.11M | 75.00K | -1.00K | -6.00K |
| Change in Accounts Receivable | -740.00K | 249.00K | -571.00K | |||
| Change in Accounts Payable | 1.34M | -5.62M | 4.70M | -3.68M | 6.45M | 1.73M |
| Change in Unearned Revenue | -997.00K | 281.00K | 1.64M | |||
| Change in Other Net Operating Assets | -236.00K | -670.00K | 88.00K | 2.28M | -2.50M | -496.00K |
| Operating Cash Flow | -22.18M | -20.77M | -10.55M | -12.85M | -12.97M | -10.28M |
| Capital Expenditures | -1.37M | -67.00K | -146.00K | -160.00K | -509.00K | -144.00K |
| Sale of Property, Plant & Equipment | 30.00K | 62.00K | ||||
| Sale (Purchase) of Intangibles | -545.00K | -250.00K | ||||
| Investment in Securities | -1.57M | -817.00K | -3.42M | |||
| Investing Cash Flow | -2.95M | -854.00K | -4.11M | -160.00K | -759.00K | -82.00K |
| Short-Term Debt Issued | 750.00K | 3.29M | ||||
| Long-Term Debt Issued | 3.74M | |||||
| Total Debt Issued | 1.75M | 4.49M | 3.29M | |||
| Short-Term Debt Repaid | -3.29M | |||||
| Long-Term Debt Repaid | -3.70M | -4.00M | -1.61M | -1.61M | -276.00K | |
| Total Debt Repaid | -1.77M | -7.00M | -4.00M | -1.61M | -1.61M | -276.00K |
| Net Debt Issued (Repaid) | -22.00K | -2.51M | -704.00K | -1.61M | -1.61M | -276.00K |
| Issuance of Common Stock | 36.72M | 38.54M | 7.26M | 5.53M | 15.83M | 20.69M |
| Repurchase of Common Stock | -374.00K | -126.00K | ||||
| Other Financing Activities | -11.44M | -5.72M | -348.00K | -773.00K | ||
| Financing Cash Flow | 25.25M | 30.31M | 6.19M | 3.44M | 13.45M | 20.42M |
| Net Cash Flow | 133.00K | 8.68M | -8.48M | -9.57M | -280.00K | 10.05M |
| Free Cash Flow | -23.55M | -20.84M | -10.70M | -13.01M | -13.48M | -10.42M |
| Free Cash Flow Margin | -560.29% | -399.81% | -183.72% | -264.83% | -6,018.30% | |
| Free Cash Flow Per Share | -3.92 | -6.70 | -34.74 | -103.56 | -192.55 | -323.35 |
| Levered Free Cash Flow | -13.97M | -13.60M | -3.35M | -8.43M | -8.21M | -5.18M |
| Unlevered Free Cash Flow | -13.96M | -13.26M | -3.24M | -8.37M | -8.15M | -5.14M |
| Cash Interest Paid | 32.00K | 222.00K | 327.00K | 388.00K | ||
| Change in Working Capital | 363.00K | -6.04M | 3.22M | -1.12M | 5.60M | 1.24M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 13.28M | 70.40M | 6.78M | 7.92M | 10.65M | 16.13M |
| Enterprise Value | 4.74M | 60.22M | 5.39M | 1.49M | -3.62M | 2.21M |
| Last Close Price | 1.70 | 12.81 | 28.75 | 43.75 | 118.87 | 393.75 |
| Forward PE | 2.56 | 2.56 | 2.56 | 2.56 | 2.56 | |
| PS Ratio | 3.07 | 13.51 | 1.16 | 1.61 | 47.55 | |
| PB Ratio | 2.27 | 17.62 | -0.76 | -5.87 | 1.65 | 1.49 |
| P/TBV Ratio | 2.67 | 21.39 | 1.78 | 1.55 | ||
| EV/Sales Ratio | 1.04 | 11.55 | 0.93 | 0.30 | ||
| Debt / Equity Ratio | 0.01 | 0.20 | -0.38 | -3.10 | 0.88 | 0.65 |
| Net Debt / Equity Ratio | -1.56 | -1.95 | 0.03 | 3.24 | -1.94 | -1.05 |
| Net Debt / EBITDA Ratio | 0.33 | 0.53 | 0.02 | 0.34 | 0.65 | 0.97 |
| Net Debt / FCF Ratio | 0.36 | 0.37 | 0.02 | 0.34 | 0.93 | 1.09 |
| Asset Turnover | 0.34 | 0.45 | 0.65 | 0.28 | 0.01 | |
| Quick Ratio | 1.23 | 0.73 | 0.27 | 0.80 | 1.53 | 3.13 |
| Current Ratio | 1.37 | 1.23 | 0.34 | 0.92 | 1.84 | 3.36 |
| Return on Equity (ROE) | -614.05% | -522.50% | -234.65% | -193.25% | ||
| Return on Assets (ROA) | -135.36% | -83.29% | -101.93% | -47.23% | -53.74% | -44.65% |
| Return on Capital Employed (ROCE) | -483.30% | -381.40% | 164.80% | -2,015.30% | -164.10% | -75.60% |
| Earnings Yield | -249.72% | -31.80% | -191.39% | -168.24% | -190.35% | -83.08% |
| FCF Yield | -182.52% | -29.60% | -157.80% | -164.38% | -126.56% | -64.63% |
| Buyback Yield / Dilution | -830.64% | -910.35% | -145.18% | -79.45% | -117.18% | -173.02% |